The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $56.91

Today's change0.00 0.00%
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $56.91

Today's change0.00 0.00%
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.

Teva Pharmaceutical Industries Ltd closed at (U.S.)$56.91.

Over the last five days, shares have lost 5.57% and are down 13.30% for the last year to date. This security has outperformed the S&P 500 by 10.04% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $56.91
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-13.30%
  • Volume0
  • Average volume (10-day)6,348,182
  • Average volume (1-month)5,281,607
  • Average volume (3-month)5,810,005
  • 52-week range(U.S.) $54.17 to (U.S.) $72.31
  • Beta0.85
  • Trailing P/E27.56×
  • P/E 1 year forward10.44×
  • Forward PEG2.61×
  • Indicated annual dividend(U.S.) $1.37
  • Dividend yield2.40%
  • Trailing EPS(U.S.) $2.06
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.99%

Based on its net profit margin of 8.99%, Teva Pharmaceutical Industries Ltd is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.79%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue4,8234,9664,9825,168
Total other revenue--------
Total revenue4,8234,9664,9825,168
Gross profit2,7712,9022,8362,889
Total cost of revenue2,0522,0642,1462,279
Total operating expense3,8134,3044,2334,226
Selling / general / administrative1,0891,1771,2211,326
Research & development361386332379
Depreciation / amortization788--
Interest expense (income), net operating--------
Unusual expense (income)304669526242
Other operating expenses, total--------
Operating income1,010662749942
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax313621557872
Income after tax120533453686
Income tax, total19388104186
Net income103539446687
Total adjustments to net income--------
Net income before extra. items103539446687
Minority interest-1302-7
Equity in affiliates-46-98
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items103539446687
Inc. avail. to common incl. extra. items103539446687
Diluted net income103539446687
Dilution adjustment0000
Diluted weighted average shares862859859861
Diluted EPS excluding extraordinary itemsvalue per share0.120.630.520.80
Dividends per sharevalue per share0.340.340.350.32
Diluted normalized EPSvalue per share0.351.301.021.02